To prospectively monitor the response in patients with locally advanced nonmucinous rectal cancer after chemoradiotherapy (CRT) using diffusion-weighted magnetic resonance imaging. The histopathologic finding was the reference standard.
Barbaro, B., Vitale, R., Valentini, V., Illuminati, S., Vecchio, F. M., Rizzo, G., Gambacorta, M. A., Crucitti, A., Coco, C., Persiani, R., Sofo, L., Bonomo, L., Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy, <<INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS>>, 2012; 83 (2): 594-599. [doi:10.1016/j.ijrobp.2011.07.017] [https://hdl.handle.net/10807/10342]
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy
Barbaro, Brunella;Vitale, Renata;Valentini, Vincenzo;Illuminati, Sonia;Vecchio, Fabio Maria;Rizzo, Giulia;Gambacorta, Maria Antonietta;Crucitti, Antonio;Coco, Claudio;Persiani, Roberto;Sofo, Luigi;Bonomo, Lorenzo
2012
Abstract
To prospectively monitor the response in patients with locally advanced nonmucinous rectal cancer after chemoradiotherapy (CRT) using diffusion-weighted magnetic resonance imaging. The histopathologic finding was the reference standard.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
